寡核苷酸
药理学
医学
临床试验
计算生物学
血液学
免疫系统
临床前试验
病理
医学物理学
免疫学
化学
生物
生物化学
DNA
作者
Judith K. Marquis,Joseph M. Grindel
出处
期刊:PubMed
[National Institutes of Health]
日期:2000-06-01
卷期号:2 (3): 258-63
被引量:25
摘要
In this brief review, guidance is provided for the safety evaluation of phosphorothioate oligonucleotides. This novel class of compounds has proved to be challenging for the preclinical development scientist, as systemic exposure can evoke sometimes dramatic responses, in terms of general functional parameters, laboratory data (hematology, clinical chemistry) and histopathology of target organs. The polyanionic profile of these compounds is discussed vis-à-vis historical data for related structures. Dose-related responses in various laboratory test species are described. The liver, kidneys and immune system are major target organs, and an experimental perspective is provided for understanding each of these in determining a safe starting dose for clinical trials with novel compounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI